Stepan Company produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company is headquartered in Northfield, Illinois.
108 articles
Dimensional Fund Advisors LP disclosed a 5.2% passive stake in Stepan Co (SCL) via managed funds as of September 30, 2026. No single fund holds more than 5% of the company's securities.
Stepan Company will release its Q3 2026 earnings on October 28, 2026, at 7:00 a.m. ET, accompanied by a conference call to discuss financial and operational performance.
Stepan Company (NYSE: SCL) will release its Q3 2026 earnings on October 28, 2026, at 7:00 a.m. ET. A conference call led by CEO Luis Rojo and CFO Ruben Velasquez will follow at 9:00 a.m. ET.
Zacks Research upgraded Stepan Company stock to Strong Buy after Q2 2026 earnings beat consensus, reporting adjusted EPS of USD 1.18 and revenue of USD 684.11 million.
Stepan Company reported 15% revenue growth to $684.11 million in Q2 2026, beating analyst estimates with an adjusted EPS of $1.18. Analysts upgraded the stock to "Strong Buy" with a price target of $8
Stepan Company secured a $500 million credit facility led by JPMorgan Chase and Bank of America, boosting borrowing capacity by $50 million for working capital and acquisitions.
Stepan Company (SCL) stock overview covers financial metrics and analyst insights across its Surfactants, Polymers, and Specialty Products segments. The report highlights the company's global operatio
Stepan Company shares closed at $61.81 on September 22, 2026, slipping 0.11% while the Nasdaq rose 2.26%. As a specialty chemicals operator, the stock's performance diverged from broader market trends
Stepan Company's stock dipped slightly after recent gains, following results showing a 4% revenue increase but a 14% drop in diluted earnings per share due to margin pressure. Investors are monitoring
Empowered Funds LLC increased its stake in specialty chemical maker Stepan by $4.95 million after the company surpassed Q2 revenue and EPS expectations.
Stepan Company reported mixed Q2 2026 financial results with stronger earnings but a six-month net loss while maintaining dividends, prompting investor analysis on converting specialty chemical assets
Various ETFs include Stepan Co stock in their portfolios, detailing fund metrics like AUM and expense ratios. This information assists investors in identifying diversified investment options primarily
Stepan Company shares have recovered over the past year despite a five-year decline, trading near their fair price-to-sales value of 0.6x. Future performance hinges on converting revenue to cash flow
Stepan Company reported approximately 2,301 employees worldwide as of March 2026, marking a 3.8% decline since 2023. Active job postings decreased by 60.9%, while the average global salary stands at $
Empowered Funds LLC increased its stake in Stepan Company by 124.8% to $8.7 million following strong quarterly earnings that beat estimates with 15% revenue growth.
Stepan Company exceeded Q2 revenue and earnings estimates, though analysts forecast a loss by 2026 despite higher price targets. The company is projected to grow faster than the broader industry throu
Stepan Co CFO Ruben Dario Velasquez settled 1,358 RSUs at $64.675 per share on August 10, 2026, withholding 398 shares for taxes. The remaining 2,716 RSUs will vest ratably over three years without a
Wall Street Zen upgraded Stepan Company (NYSE:SCL) to a "Buy" rating following strong quarterly earnings that exceeded EPS and revenue expectations. The positive outlook drove shares up 1.8% to $65.14
Stepan Company reported strong Q2 2026 sales and net income while affirming its quarterly dividend. Analysts note significant undervaluation via DCF models despite mixed shareholder returns over three
Stepan Company exceeded Q2 revenue and EPS expectations, reporting $684 million and $1.00 respectively. Analysts forecast a 2026 loss but raised price targets, expecting Stepan to outpace industry rev
Stepan Company reported Q2 2026 sales of US$684.11 million and affirmed its quarterly dividend. Analysts highlight potential undervaluation against peers despite recent stock momentum.
The Public Employees Retirement System of Ohio reduced its stake in Stepan Company by 94.1% in Q1, while the firm reported strong earnings with 15% revenue growth.
Stepan Company reported strong Q2 results and affirmed its dividend, citing governance changes. While valuation models suggest the stock is undervalued, risks from net losses remain.
Stepan Company reaffirmed its dividend despite a net loss in the first half of 2026, aiming to clarify long-term strategy. Analysts project significant revenue growth by 2029, suggesting a potential 1
Stepan Co reported Q2 2026 revenue of $684.1 million with doubled net income, driven by higher prices and improved product mix in surfactants.
Stepan Company VP Matthew John Eaken filed a beneficial ownership statement disclosing 9,319 direct shares and 3,102 indirect shares via an ESOP II Trust. The filing also details his holdings in stock
Stepan Company exceeded Q2 2026 expectations with $1.18 EPS and $684.1M revenue, up 15% YoY. Growth was driven by strong organic sales volume and performance in its surfactants division.
Stepan Company reported second-quarter adjusted earnings per share of $1.18, significantly surpassing FactSet estimates of $0.61. This result highlights the company's robust financial performance duri
Stepan Co. beat Q2 earnings and revenue estimates, posting $1.18 per share versus $0.61 expected and $684.11 million in revenue. While shares gained year-to-date, future performance hinges on manageme
Stepan Company reported a 102% surge in Q2 2026 net income driven by volume growth and margin recovery in Surfactants and Polymers. Simultaneously, the firm plans to reduce its global salaried workfor
ChemBrief